Integral Diagnostics Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 0.074x

Integral Diagnostics Ltd cash flow conversion efficiency. Based on the latest financial reports, Integral Diagnostics Ltd (IDX) has a cash flow conversion efficiency ratio of 0.074x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$51.60 Million ≈ $36.51 Million USD) by net assets (AU$693.94 Million ≈ $491.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Integral Diagnostics Ltd (2012–2025)

Cash flow conversion efficiency of Integral Diagnostics Ltd from 2012 to 2025. This chart illustrates how Integral Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Integral Diagnostics Ltd share price for real-time trading data and today's change.

Integral Diagnostics Ltd Cash Flow Conversion Ratio Explained

Integral Diagnostics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Integral Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Integral Diagnostics Ltd ranked by their cash flow conversion efficiency. Also see IDX company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
LifeSemantics Corp. KQ:347700	0.063x
Swaraj Engines Limited NSE:SWARAJENG	0.231x
CHA Biotech Co. Ltd KQ:085660	0.000x
Hunan Kylinsec Technology Co. Ltd. A SHG:688152	N/A
Zhuhai Zhongfu Enterprise Co Ltd SHE:000659	-2.091x
CNFC Overseas Fishery Co Ltd SHE:000798	0.072x
Daewoong KO:003090	0.036x
PLAYWAY SA WAR:PLW	0.120x

Annual Cash Flow Conversion Efficiency for Integral Diagnostics Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Integral Diagnostics Ltd from 2012 to 2025. Review IDX free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$693.94 Million ≈ $491.01 Million	AU$73.77 Million ≈ $52.20 Million	0.106x	-51.52%
2024-06-30	AU$301.71 Million ≈ $213.48 Million	AU$66.16 Million ≈ $46.81 Million	0.219x	+14.54%
2023-06-30	AU$373.05 Million ≈ $263.96 Million	AU$71.42 Million ≈ $50.53 Million	0.191x	+79.19%
2022-06-30	AU$347.24 Million ≈ $245.70 Million	AU$37.10 Million ≈ $26.25 Million	0.107x	-60.88%
2021-06-30	AU$254.74 Million ≈ $180.24 Million	AU$69.57 Million ≈ $49.23 Million	0.273x	+14.95%
2020-06-30	AU$228.33 Million ≈ $161.56 Million	AU$54.25 Million ≈ $38.39 Million	0.238x	-10.90%
2019-06-30	AU$127.22 Million ≈ $90.02 Million	AU$33.92 Million ≈ $24.00 Million	0.267x	-6.06%
2018-06-30	AU$93.42 Million ≈ $66.10 Million	AU$26.52 Million ≈ $18.76 Million	0.284x	+12.83%
2017-06-30	AU$90.35 Million ≈ $63.93 Million	AU$22.73 Million ≈ $16.08 Million	0.252x	-12.23%
2016-06-30	AU$83.92 Million ≈ $59.38 Million	AU$24.05 Million ≈ $17.02 Million	0.287x	-29.91%
2015-06-30	AU$41.84 Million ≈ $29.60 Million	AU$17.11 Million ≈ $12.11 Million	0.409x	-67.85%
2014-06-30	AU$2.90 Million ≈ $2.06 Million	AU$3.70 Million ≈ $2.61 Million	1.272x	-13.56%
2013-06-30	AU$2.54 Million ≈ $1.80 Million	AU$3.74 Million ≈ $2.65 Million	1.472x	+55.94%
2012-06-30	AU$2.54 Million ≈ $1.80 Million	AU$2.40 Million ≈ $1.70 Million	0.944x	--

About Integral Diagnostics Ltd

AU:IDX Australia Diagnostics & Research

Market Cap

$459.13 Million

AU$648.89 Million AUD

Market Cap Rank

#12350 Global

#318 in Australia

Share Price

AU$1.74

Change (1 day)

+0.58%

52-Week Range

AU$1.71 - AU$2.68

All Time High

AU$5.00